Compare Merck Tbk. (MERK) vs Trimegah Bangun Persada Tbk. (NCKL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck Tbk. vs Trimegah Bangun Persada Tbk. — how do they compare? Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume), while Trimegah Bangun Persada Tbk. trades at Rp940 (market cap 60.26T, 66.68M 24h volume). The key difference: Trimegah Bangun Persada Tbk. is far larger — about 34.2× Merck Tbk.'s market cap, and Trimegah Bangun Persada Tbk. is more actively traded (66.68M versus 63K). Which is the better fit depends on your goals.
| MERK | NCKL | |
|---|---|---|
Market Cap | 1.76T | 60.26T |
Volume | 63K | 66.68M |
Lot | 630 | 666.76K |
Turnover | 243.97M | 62.63B |
Average Price | 3,872.46 | 939.35 |
Value | 243.97M | 62.63B |
Indicative Equilibrium Price | 3,900 | 940 |
Indicative Equilibrium Volume | 1 | 13.51K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →About Trimegah Bangun Persada Tbk.
PT Trimegah Bangun Persada Tbk. (the Company) was established in Indonesia based on Notarial Deed of Erna Priyono, S.H., No. 03 dated September 6, 2004.
Read more on NCKL →
